- Home
- CRNX vs USAC Comparison
CRNX vs USAC Comparison
Compare CRNX & USAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- USAC
- Stock Information
- Founded
- CRNX 2008
- USAC 1998
- Country
- CRNX United States
- USAC United States
- Employees
- CRNX N/A
- USAC N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- USAC Natural Gas Distribution
- Sector
- CRNX Health Care
- USAC Utilities
- Exchange
- CRNX Nasdaq
- USAC Nasdaq
- Market Cap
- CRNX 2.8B
- USAC N/A
- IPO Year
- CRNX 2018
- USAC N/A
- Fundamental
- Price
- CRNX $30.51
- USAC $25.20
- Analyst Decision
- CRNX Strong Buy
- USAC Hold
- Analyst Count
- CRNX 10
- USAC 4
- Target Price
- CRNX $75.00
- USAC $26.00
- AVG Volume (30 Days)
- CRNX 942.0K
- USAC 266.6K
- Earning Date
- CRNX 05-08-2025
- USAC 05-06-2025
- Dividend Yield
- CRNX N/A
- USAC 8.33%
- EPS Growth
- CRNX N/A
- USAC 67.81
- EPS
- CRNX N/A
- USAC 0.67
- Revenue
- CRNX $760,000.00
- USAC $966,407,000.00
- Revenue This Year
- CRNX $343.70
- USAC $6.58
- Revenue Next Year
- CRNX $733.93
- USAC $4.74
- P/E Ratio
- CRNX N/A
- USAC $37.54
- Revenue Growth
- CRNX N/A
- USAC 10.03
- 52 Week Low
- CRNX $24.10
- USAC $21.06
- 52 Week High
- CRNX $62.53
- USAC $30.10
- Technical
- Relative Strength Index (RSI)
- CRNX 46.97
- USAC 53.79
- Support Level
- CRNX $29.05
- USAC $24.17
- Resistance Level
- CRNX $30.99
- USAC $25.06
- Average True Range (ATR)
- CRNX 1.43
- USAC 0.66
- MACD
- CRNX -0.09
- USAC 0.17
- Stochastic Oscillator
- CRNX 32.27
- USAC 64.14
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.